S
SynGen
Comprehensive biotechnology solutions with expert support and custom-tailored research products
About SynGen
Syngen Inc. operates in the biotechnology sector, providing a wide array of research solutions tailored to meet the unique goals of its clients. The company serves a diverse clientele, including research institutions and laboratories, by offering high-quality, reliable products and services. Syngen Inc. differentiates itself by not only supplying biotechnology products but also acting as a trusted collaborator, ensuring that clients receive comprehensive support throughout their research endeavors. The business model focuses on delivering custom solutions, which allows the company to generate revenue through personalized service offerings. Syngen Inc. is committed to maintaining quality and effectiveness in its product line, which is supported by a team of expert scientists dedicated to assisting clients in achieving their research objectives.
Source: Dealroom company dataAt a glance
- Founded
- 2000
- Headquarters
- San Carlos, United States
- Sector
- Biotechnology
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- BCBay City Capital
Series B and later1 investor entered at this stage
GE Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about SynGen on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See SynGen on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.